Researchers have developed a method to detect build-up of amyloid beta in the brain, a characteristic of Alzheimer’s disease, from biomarkers in blood samples.
Researchers have developed a method to detect build-up of amyloid beta in the brain, a characteristic of Alzheimer’s disease, from biomarkers in blood samples.